BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 25584696)

  • 1. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.
    Choi YH; Yu AM
    Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance transporters and modulation.
    Tan B; Piwnica-Worms D; Ratner L
    Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transporter-mediated multidrug resistance and its modulation by Chinese medicines and other herbal products.
    Wang Z; Ravula R; Cao M; Chow M; Huang Y
    Curr Drug Discov Technol; 2010 Mar; 7(1):54-66. PubMed ID: 20156136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.
    Shukla S; Wu CP; Ambudkar SV
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):205-23. PubMed ID: 18248313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human ABC transporter ABCG2 in cancer chemotherapy: drug molecular design to circumvent multidrug resistance.
    Ishikawa T; Saito H; Hirano H; Inoue Y; Ikegami Y
    Methods Mol Biol; 2012; 910():267-78. PubMed ID: 22821599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies for overcoming multidrug resistance.
    Nobili S; Landini I; Giglioni B; Mini E
    Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators.
    M F Gonçalves B; S P Cardoso D; U Ferreira MJ
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
    Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS
    Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status on marine products with reversal effect on cancer multidrug resistance.
    Abraham I; El Sayed K; Chen ZS; Guo H
    Mar Drugs; 2012 Oct; 10(10):2312-2321. PubMed ID: 23170086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressors as multidrug resistance reversal agents.
    Morjani H; Madoulet C
    Methods Mol Biol; 2010; 596():433-46. PubMed ID: 19949935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resitance by natural substances from plants.
    Molnár J; Engi H; Hohmann J; Molnár P; Deli J; Wesolowska O; Michalak K; Wang Q
    Curr Top Med Chem; 2010; 10(17):1757-68. PubMed ID: 20645919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing multidrug resistance by tyrosine kinase inhibitors.
    He M; Wei MJ
    Chin J Cancer; 2012 Mar; 31(3):126-33. PubMed ID: 22237041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.